Crossreactivity in Antiepileptic Drug Monitoring: Reply to: Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy-A monocenter survey.

We have read with great interest the article ‘Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy–A monocenter survey’ (Steinhoff et al.; 2017 May; 48:11–14).[1] However, we wish to complement this article’s use of laboratory testing for brivaracetam and levetiracetam analysis.

5
DIC
0